Warfarin anticoagulation and outcomes in patients with atrial fibrillation - A systematic review and metaanalysis

被引:206
|
作者
Reynolds, MW
Fahrbach, K
Hauch, O
Wygant, G
Estok, R
Cella, C
Nalysnyk, L
机构
[1] MetaWorks Inc, Medford, MA USA
[2] AstraZeneca LP, Wilmington, DE USA
关键词
anticoagulation; atrial fibrillation; warfarin;
D O I
10.1378/chest.126.6.1938
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To examine the relationship between international normalized ratio (INR) and Outcomes (major bleeding events and strokes) in patients with atrial fibrillation (AF) receiving anticoagulation with warfarin. Methods: A systematic review and metaanalysis of studies published in the English language between January 1, 1985, and October 30, 2002, was performed. MEDLINE (PubMed), Current Contents, and relevant reference lists were searched. Studies enrolling patients with nonvalvular AF receiving warfarin anticoagulation were eligible for inclusion if they reported stroke and/or major bleeding events in relation to INR, or time spent in therapeutic range. The risk of bleeds in overanticoagulated patients (INR > 3) and the risk of strokes in underanticoagulated patients (INR < 2) were assessed. Results: Twenty-one studies (6,248 patients) met all inclusion criteria. Of the 21 studies, a target conventional INR of 2 to 3 was used in 9 studies. An INR < 2, compared with an INR : 2, was associated with an odds ratio (OR) for ischemic events of 5.07 (95% confidence interval [CI], 2.92 to 8.80). An INR > 3, compared with an INR :5 3, was associated with an OR for bleeding events of 3.21 (95% CI, 1.24 to 8.28). On average, in the four studies with a target INR range of 2 to 3, patients with AF receiving warfarin spent 61% of time within, 13% of time above, and 26% below the therapeutic range. Conclusion: Available evidence indicates that in patients with nonvalvular AF, the risk of ischemic stroke with insufficient warfarin anticoagulation (INR < 2), and the risk of bleeding events with overanticoagulation (INR > 3) are significantly higher relative to patients with AF maintained within the recommended INR of 2 to 3. However, the published data are sparse, heterogeneous, and primarily reported from clinical trials. More studies evaluating clinical outcomes in relation to INR are needed, especially in a real-world setting.
引用
收藏
页码:1938 / 1945
页数:8
相关论文
共 50 条
  • [1] Warfarin anticoagulation and outcomes in atrial fibrillation patients: A systematic review and meta-analysis
    Reynolds, MW
    Nalysnyk, L
    Fahrbach, K
    Hauch, O
    Wygant, G
    Estok, R
    Frame, D
    Cella, C
    Scheye, R
    Ross, S
    VALUE IN HEALTH, 2004, 7 (03) : 320 - 320
  • [2] Warfarin adherence and anticoagulation control in atrial fibrillation patients: a systematic review
    Ababneh, M.
    Nasser, S. A.
    Rababa'h, A.
    Ababneh, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (24) : 7926 - 7933
  • [3] Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review
    Caturano, A.
    Brunelli, V.
    Galiero, R.
    Spiezia, S.
    Rinaldi, L.
    Sasso, F. C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (04) : 1068 - 1069
  • [4] A review of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation
    Abdelhafiz, AH
    CLINICAL THERAPEUTICS, 2001, 23 (10) : 1628 - 1636
  • [5] The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
    Koroleva, Lyubov Yu.
    Kolesnichenko, Irina V.
    Nosov, Vladimir P.
    Zlobin, Maxim V.
    Abelevich, Dmitry I.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (05) : 553 - 557
  • [6] Quality and predictors of anticoagulation with warfarin in atrial fibrillation patients
    Parakramawansha, R.
    Quinn, T. J.
    Tait, R. C.
    Wilson, M. R.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 54 - 54
  • [7] Quality and predictors of anticoagulation with Warfarin in atrial fibrillation patients
    Wilson, M. R.
    Parakramawansha, R.
    Quinn, T. J.
    Tait, R. C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 42 - 42
  • [8] Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin
    Kim, Eun-Jeong
    Ozonoff, Al
    Hylek, Elaine M.
    Berlowitz, Dan R.
    Ash, Arlene S.
    Miller, Donald R.
    Zhao, Shibei
    Reisman, Joel I.
    Jasuja, Guneet K.
    Rose, Adam J.
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (01) : 70 - 77
  • [9] Early versus Late Anticoagulation for Ischemic Stroke Associated With Atrial Fibrillation: An Updated Systematic Review and MetaAnalysis
    Akbar, Usman
    Anwar, Rana Usman
    Shamshad, Talha
    Ali, Ahmed
    Umer, Ahmed Muaaz
    Waqas, Muhammad
    Khan, Muhammad Aslam
    Vorla, Mounica
    Muhibullah
    Shafique, Nouman
    Mukhtar, Sonia
    Khan, Muhammad Adnan
    Raza, Munis
    Haider, Ali
    Dani, Sourbha
    CIRCULATION, 2023, 148
  • [10] ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION - UNDERUSE OF WARFARIN IS MULTIFACTORIAL
    DOW, L
    BERTAGNE, B
    BRITISH MEDICAL JOURNAL, 1993, 307 (6917): : 1492 - 1493